Title

Treatment and Management of ANCA-Associated Vasculitis

Authoring Organization

Publication Month/Year

July 8, 2021

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Infant, Older adult

Health Care Settings

Ambulatory

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Assessment and screening, Treatment, Management

Diseases/Conditions (MeSH)

D056653 - Rheumatoid Vasculitis, D056647 - Systemic Vasculitis, D056648 - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, D014657 - Vasculitis, D014890 - Granulomatosis with Polyangiitis, D013700 - Giant Cell Arteritis

Keywords

vasculitis, ANCA, Antineutrophil Cytoplasmic Antibody, polyangiitis, GCA, giant cell arteritis

Source Citation

Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2021 Aug;73(8):1088-1105. doi: 10.1002/acr.24634. Epub 2021 Jul 8. PMID: 34235880.

Supplemental Methodology Resources

Evidence Tables, Project Plan, Project Plan